Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia : an international collaboration
Authors:ID Mancini, John (Author)
ID Ryomoto, Arnold (Author)
ID Ruel, Isabelle (Author)
ID Iatan, Iulia (Author)
ID Raal, Frederick J. (Author)
ID Santos, Raul D. (Author)
ID Grošelj, Urh (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (2,35 MB)
MD5: DC9037EF214D7A375EB011D7623FFEFF
 
URL URL - Source URL, visit https://www.atherosclerosis-journal.com/article/S0021-9150(25)01488-1/fulltext
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background and aims: Diagnosis of Homozygous Familial Hypercholesterolaemia (HoFH) relies on untreated low-density lipoprotein-cholesterol (LDL-C) which is often unknown. We determine whether untreated LDL-C can be imputed from treated LDL-C in HoFH. Methods: Two groups with HoFH were identified: Group 1 (n = 193) from Canada, Brazil and South Africa; Group 2 (n = 206) from the HoFH International Clinical Collaboration. Pre- and post-treatment LDL-C and lipid lowering therapy (LLT) intensity from Group 1 were used to develop a regression model and applied to treated LDL-C in Group 2 to impute pre-treatment LDL-C. The same process was performed in reverse. A final imputation model was created from combining both groups. Results: There was a curvilinear relationship between the expected and observed % lowering of LDL-C on LLT (r = 0.3923, p < 0.0001, Standard Error [SE] = 23 %). Using this relationship, LDL-C was imputed from treated values and showed significant correlation with pre-treatment LDL-C (r = 0.71, p < 0.001; mean values 13.4 ± 4.7 [Standard Deviation] and 13.6 ± 7.3 mmol/L, respectively, ns). Concordance between actual and imputed values ≥ 10 or <10 mmol/L was 80 %. Whereas 36 % of patients had treated LDL-C ≥ 10 mmol/L, 64 % had treated or imputed pre-treatment LDL-C ≥ 10 mmol/L. Conclusions: In HoFH, the response to LLT can be quantified and used to impute untreated LDL-C from treated LDL-C. Imputation may augment awareness of possible HoFH in treated subjects lacking records of untreated LDL-C.
Keywords:homozygous familial hypercholesterolaemia, low density lipoprotein-cholesterol, imputation, LDL-receptor, lipid lowering therapy, estimated untreated low-density lipoproteincholesterol
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 1-7
Numbering:Vol. 412, [article no.] 120590
PID:20.500.12556/DiRROS-29662 New window
UDC:616.1
ISSN on article:1879-1484
DOI:10.1016/j.atherosclerosis.2025.120590 New window
COBISS.SI-ID:280043011 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 1. 6. 2026;
Publication date in DiRROS:02.06.2026
Views:29
Downloads:14
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Atherosclerosis
Shortened title:Atherosclerosis
Publisher:Elsevier
ISSN:1879-1484
COBISS.SI-ID:23193093 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back